Welcome to Inmar Intelligence, recently certified a Great Place to Work®! Through curiosity and the intelligent use of data and technology, we make businesses smarter to improve consumers’ lives. We’ve been a partner to brands, retailers and healthcare organizations for over 40 years — designing, building and operating reliable, dynamic solutions to create greater efficiencies and enable connections that unlock the potential of sophisticated marketplaces. $120B of commerce runs through our market-driven platforms each year. Insights created through Analytics, AI, and Machine Learning drive faster actions and more successful outcomes — none of which would be possible without happy, healthy, motivated talented team members. Our supportive, flexible, rewarding work culture gives team members the power and independence to solve challenges, capitalize on opportunities, and help businesses improve the lives of consumers.
Location: United States, North Carolina, Winston-Salem
Employees: 1001-5000
Founded date: 1980
Investors 2
Date | Name | Website |
- | Detroit Ve... | detroit.vc |
- | OMERS Grow... | omerspriva... |
Mentions in press and media 28
Date | Title | Description |
01.10.2024 | Zappi Announces Strategic Leadership Transition to Drive Next Phase of Growth and Accelerate Consumer Insights Transformation | zappi Aaron Kechley appointed CEO; founder and longtime CEO Steve Phillips to step into Executive Chair and Chief Innovation Officer roles BOSTON, Oct. 1, 2024 /PRNewswire-PRWeb/ -- Zappi, a leading consumer insights software provider, toda... |
27.09.2024 | The Future of Influencer Marketing: Data-Driven Precision with Commerce Fitscore™ | In the fast-paced world of marketing, data is the new gold. Inmar Intelligence has struck a rich vein with its latest innovation: Commerce Fitscore™. This tool promises to revolutionize how brands select influencers, marrying data with crea... |
26.09.2024 | Inmar Intelligence Launches Commerce Fitscore™ | Inmar Intelligence, a leading data and technology company, announced the launch of Commerce Fitscore™, the first solution of its kind that removes the subjectivity in creator selection and aligns creator selection with actual purchase behav... |
13.08.2024 | Inmar Post-Purchase Solutions Teams Up with FedEx Office to Expand its National Network of Package-Free Return Drop-Off Locations | WINSTON-SALEM, N.C., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Inmar Post-Purchase Solutions, a joint venture between Inmar and Doddle, Inc., a part of Blue Yonder, today announced the addition of nearly 2,000 return drop-offs at FedEx Office locat... |
05.04.2024 | Punchey Inc. appoints Sylvain Mansier as Chief Executive Officer | Punchey Inc., a leading provider of automation and point-of-sale technology for consumer services businesses, proudly announces Sylvain Mansier as the company’s Chief Executive Officer, effective immediately. In his new role, Sylvain is poi... |
12.03.2024 | Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution | COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product... |
03.04.2023 | Camber Pharmaceuticals recalls pneumonia medication due to heart risk | Camber Pharmaceuticals has recalled some of its pneumonia medicine because it could be contaminated with a bacteria that can permanently damage someone's heart. Atovaquone Oral Suspension — specifically lot #E220182 — has a potential Bacill... |
31.03.2023 | Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750mg/5mL Due to Potential Bacillus Cereus Contamination in the Product | COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement Summary Comp... |
23.12.2022 | Accord Healthcare Inc. Issues Nationwide Voluntary Recall of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial Lot # R2200232 Due to Product Mix-up | DURHAM, N.C., Dec. 23, 2022 /PRNewswire/ -- Accord Healthcare, Inc. is voluntarily recalling a single lot of Daptomycin for Injection 500 mg/vial, and Daptomycin for Injection 350 mg/vial product contained in cartons imprinted with lot # R2... |
31.03.2022 | ‘Go heavy now’: Brands rush to tap student-athletes before regulations get trickier | Ohio State University’s NIL guidelines indicate that athletes are prohibited from entering NIL deals if it conflicts with an Ohio State brand agreement. For instance, athletes are not allowed to enter an NIL agreement if it requires them to... |
Show more